Low-Dose Naltrexone Fails in Fibromyalgia Treatment Trial
Low-dose naltrexone does not provide real clinical benefit for patients with fibromyalgia compared to placebo, according to a clinical trial.
Medscape Medical News
source https://www.medscape.com/viewarticle/low-dose-naltrexone-fails-outperform-placebo-pain-2026a1000iy0?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/low-dose-naltrexone-fails-outperform-placebo-pain-2026a1000iy0?src=rss
Comments
Post a Comment